![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 21
2022
Trapp, Elisabeth K.; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Mueller, Volkmar; Harbeck, Nadia; Lorenz, Ralf; Schumacher, Claudia; Heinrich, Georg; Schochter, Fabienne; de Gregorio, Amelie; Tzschaschel, Marie; Rack, Brigitte; Janni, Wolfgang und Friedl, Thomas W. P.
(2022):
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
In: Cancers, Bd. 14, Nr. 16, 3949
de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg und Harbeck, Nadia
(2022):
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
In: British Journal of Cancer, Bd. 126, Nr. 12: S. 1715-1724
2021
Friedl, Thomas W. P.; Fehm, Tanja; Mueller, Volkmar; Lichtenegger, Werner; Blohmer, Jens; Lorenz, Ralf; Forstbauer, Helmut; Fink, Visnja; Bekes, Inga; Huober, Jens; Jueckstock, Julia; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Heinrich, Georg; Haeberle, Lothar; Fasching, Peter A.; Beckmann, Matthias W.; Coleman, Robert E.; Janni, Wolfgang und Rack, Brigitte
(2021):
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment A Phase 3 Randomized Clinical Trial.
In: Jama Oncology, Bd. 7, Nr. 8: S. 1149-1157
2020
de Gregorio, Amelie; Haberle, Lothar; Fasching, Peter A.; Müller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Friedl, Thomas W. P.; Bauer, Emanuel; de Gregorio, Nikolaus; Deniz, Miriam; Fink, Visnja; Bekes, Inga; Andergassen, Ulrich; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Blohmer, Jens-Uwe; Fehm, Tanja N.; Heinrich, Georg; Lato, Krisztian; Beckmann, Matthias W.; Rack, Brigitte und Janni, Wolfgang
(2020):
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
In: Breast Cancer Research, Bd. 22, Nr. 1, 111
Bekes, Inga; Eichler, Martin; Singer, Susanne; Friedl, Thomas W. P.; Harbeck, Nadia; Rack, Brigitte; Forstbauer, Helmut; Dannecker, Christian; Huober, Jens; Kiechle, Marion; Lato, Krisztian; Janni, Wolfgang und Fink, Visnja
(2020):
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial.
In: Clinical Breast Cancer, Bd. 20, Nr. 6: S. 439-447
2019
Deniz, Miriam; DeGregorio, Amelie; DeGregorio, Nikolaus; Bekes, Inga; Widschwendter, Peter; Schochter, Fabienne; Ernst, Kristina; Scholz, Christoph; Bauer, Emanuel C. A.; Aivazova-Fuchs, Viktoria; Weissenbacher, Tobias; Kost, Bernd; Jueckstock, Julia; Andergassen, Ullrich; Steidl, Julia; Trapp, Elisabeth; Fasching, Peter A.; Haeberle, Lothar; Beckmann, Matthias W.; Schneeweiss, Andreas; Schrader, Iris; Janni, Wolfgang; Rack, Brigitte und Friedl, Thomas W. P.
(2019):
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
In: Breast, Bd. 44: S. 81-89
Trapp, Elisabeth; Janni, Wolfgang; Schindlbeck, Christian; Jueckstock, Julia; Andergassen, Ulrich; de Gregorio, Amelie; Alunni-Fabbroni, Marianna; Tzschaschel, Marie; Polasik, Arkadius; Koch, Julian G.; Friedl, Thomas W. P.; Fasching, Peter A.; Haeberle, Lothar; Fehm, Tanja; Schneeweiss, Andreas; Beckmann, Matthias W.; Pantel, Klaus; Müller, Volkmar; Rack, Brigitte und Scholz, Christoph
(2019):
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
In: Jnci-Journal of the National Cancer Institute, Bd. 111, Nr. 4, djy152: S. 380-387
2018
Alunni-Fabbroni, Marianna; Majunke, Leonie; Trapp, Elisabeth K.; Tzschaschel, Marie; Mahner, Sven; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Beck, Thomas; Lorenz, Ralf; Friedl, Thomas W. P.; Janni, Wolfgang und Rack, Brigitte
(2018):
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
In: BMC Cancer
18:141
[PDF, 1MB]
Hepp, Philip; Fasching, Peter A.; Beckmann, Matthias W.; Fehm, Tanja; Salmen, Jessica; Hagenbeck, Carsten; Jaeger, Bernadette; Widschwendter, Peter; Gregorio, Nikolaus de; Schochter, Fabienne; Mahner, Sven; Harbeck, Nadia; Weissenbacher, Tobias; Kurt, Ayse-Guel; Friedl, Thomas W. P.; Janni, Wolfgang und Rack, Brigitte
(2018):
Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial.
In: Clinical Breast Cancer, Bd. 18, Nr. 5, E1103-E1110
Mutschler, Nikola S.; Scholz, Christoph; Friedl, Thomas W. P.; Zwingers, Thomas; Fasching, Peter A.; Beckmann, Matthias W.; Fehm, Tanja; Mohrmann, Svjetlana; Salmen, Jessica; Ziegler, Carola; Jaeger, Bernadette; Widschwendter, Peter; Gregorio, Nikolaus de; Schochter, Fabienne; Mahner, Sven; Harbeck, Nadia; Weissenbacher, Tobias; Jückstock, Julia; Janni, Wolfgang und Rack, Brigitte
(2018):
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
In: Clinical Breast Cancer, Bd. 18, Nr. 2: S. 175-183
Schochter, Fabienne; Rack, Brigitte; Tzschaschel, Marie; Polasik, Arkadius; Andergassen, Ulrich; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Schneeweiss, Andreas; Müller, Volkmar; Pantel, Klaus; Gade, Jörg; Lorenz, Ralf; Rezai, Mahdi; Tesch, Hans; Soeling, Ulrike; Fehm, Tanja; Mahner, Sven; Schindlbeck, Christian; Lichtenegger, Werner; Beckmann, Matthias W.; Fasching, Peter A.; Janni, Wolfgang und Friedl, Thomas W. P.
(2018):
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
In: Oncology Research and Treatment, Bd. 41, Nr. 3: S. 93-98
Bauer, Emanuel C. A.; Schochter, Fabienne; Widschwendter, Peter; DeGregorio, Amelie; Andergassen, Ulrich; Friedl, Thomas W. P.; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Beckmann, Matthias W.; Pantel, Klaus; Janni, Wolfgang; Rack, Brigitte und Scholz, Christoph
(2018):
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5years after adjuvant treatment.
In: Breast Cancer Research and Treatment, Bd. 171, Nr. 3: S. 571-580
2017
Schramm, Amelie; Schochter, Fabienne; Friedl, Thomas W. P.; Greqorio, Nikolaus de; Andergassen, Ulrich; Alunni-Fabbroni, Marianna; Trapp, Elisabeth; Jaeger, Bernadette; Heinrich, Georg; Camara, Oumar; Decker, Thomas; Ober, Angelika; Mahner, Sven; Fehm, Tanja N.; Pantel, Klaus; Fasching, Peter A.; Schneeweiss, Andreas; Janni, Wolfgang und Rack, Brigitte K.
(2017):
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
In: Clinical Breast Cancer, Bd. 17, Nr. 4: S. 279-285
2016
Koenig, Alexander; Vilsmaier, Theresa; Rack, Brigitte; Friese, Klaus; Janni, Wolfgang; Jeschke, Udo; Andergassen, Ulrich; Trapp, Elisabeth; Jückstock, Julia; Jaeger, Bernadette; Alunni-Fabbroni, Marianna; Friedl, Thomas W. P. und Weissenbacher, Tobias
(2016):
Determination of Interleukin-4,-5,-6,-8 and-13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
In: Anticancer Research, Bd. 36, Nr. 6: S. 3123-3130
Hepp, Philip; Andergassen, Ulrich; Jäger, Bernadette; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Friedl, Thomas W. P.; Hecker, Nadeschda; Lorenz, Ralf; Fasching, Peter; Schneeweiss, Andreas; Fehm, Tanja; Janni, Wolfgang und Rack, Brigitte
(2016):
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
In: Anticancer Research, Bd. 36, Nr. 9: S. 4771-4776
Schramm, Amelie; Friedl, Thomas W. P.; Schochter, Fabienne; Scholz, Christoph; De Gregorio, Nikolaus; Huober, Jens; Rack, Brigitte; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Müller, Volkmar; Schneeweiss, Andreas; Pantel, Klaus; Meier-Stiegen, Franziska; Hartkopf, Andreas; Taran, Florin-Andrei; Wallwiener, Diethelm; Janni, Wolfgang und Fehm, Tanja
(2016):
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
In: Archives of Gynecology and Obstetrics, Bd. 293, Nr. 2: S. 271-281
Schwentner, Lukas; Harbeck, Nadia; Singer, Susanne; Eichler, Martin; Rack, Brigitte; Forstbauer, Helmut; Wischnik, Arthur; Scholz, Christoph; Huober, Jens; Friedl, Thomas W. P.; Weissenbacher, Tobias; Härtl, Kristin; Kiechle, Marion; Janni, Wolfgang und Fink, Visnja
(2016):
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
In: Breast, Bd. 27: S. 69-77
Janni, Wolfgang J.; Rack, Brigitte; Terstappen, Leon W. M. M.; Pierga, Jean-Yves; Taran, Florin-Andrei; Fehm, Tanja; Hall, Carolyn; Groot, Marco R. de; Bidard, François-Clement; Friedl, Thomas W. P.; Fasching, Peter A.; Brucker, Sara Y.; Pantel, Klaus und Lucci, Anthony
(2016):
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.
In: Clinical Cancer Research, Bd. 22, Nr. 10: S. 2583-2593
Jueckstock, Julia; Rack, Brigitte; Friedl, Thomas W. P.; Scholz, Christoph; Steidl, Julia; Trapp, Elisabeth; Tesch, Hans; Forstbauer, Helmut; Lorenz, Ralf; Rezai, Mahdi; Häberle, Lothar; Alunni-Fabbroni, Marianna; Schneeweiss, Andreas; Beckmann, Matthias W.; Lichtenegger, Werner; Fasching, Peter A.; Pantel, Klaus und Janni, Wolfgang
(2016):
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
In: BMC Cancer
16:401
[PDF, 1MB]
2015
Jäger, Bernadette A. S.; Finkenzeller, Charlotte; Bock, Carolin; Majunke, Leonie; Jueckstock, Julia K.; Andergassen, Ulrich; Neugebauer, Julia K.; Pestka, Aurelia; Friedl, Thomas W. P.; Jeschke, Udo; Janni, Wolfgang; Doisneau-Sixou, Sophie F. und Rack, Brigitte K.
(2015):
Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.
In: Translational Oncology, Bd. 8, Nr. 6: S. 509-516
[PDF, 493kB]
Widschwendter, Peter; Friedl, Thomas W. P.; Schwentner, Lukas; DeGregorio, Nikolaus; Jaeger, Bernadette; Schramm, Amelie; Bekes, Inga; Deniz, Miriam; Lato, Krisztian; Weissenbacher, Tobias; Kost, Bernd; Andergassen, Ulrich; Jueckstock, Julia; Neugebauer, Julia; Trapp, Elisabeth; Fasching, Peter A.; Beckmann, Matthias W.; Schneeweiss, Andreas; Schrader, Ines; Rack, Brigitte; Janni, Wolfgang und Scholz, Christoph
(2015):
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
In: Breast Cancer Research
17:129
[PDF, 1MB]